Omada Health
OMDANASDAQHealthcare● Active
$17.88
$-0.05(-0.28%)
Market Cap$1.1B
P/E Ratio—
52W High$28.4
52W Low$10.28
Omada Health (OMDA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OMDA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.05
Est. -$0.13 · +60.8%
Revenue
$0.08B
Est. $0.07B · +5.3%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
OMDA reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.05 | — | — | — | $0.08B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.13 | -$0.05 | +60.8% | $0.08B | $0.07B | +5.3% |
| ▲ Q1 FY2026 | Mar 5, 2026 | $0.01 | $0.13 | +1427.6% | $0.08B | $0.07B | +8.0% |
| ▲ Q4 FY2025 | Nov 6, 2025 | -$0.10 | $0.02 | +120.0% | $0.07B | $0.07B | -1.5% |
| ▲ Q3 FY2025 | Aug 7, 2025 | -$0.10 | -$0.09 | +10.0% | $0.06B | $0.06B | +10.7% |
| ◌ Q2 FY2025 | May 9, 2025 | — | — | — | — | — | — |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.05
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.05
EPS Est.
-$0.13
EPS Surpr.
+60.8%
Revenue
$0.08B
Q1 FY2026
Mar 5, 2026Beat
EPS Actual
$0.13
EPS Est.
$0.01
EPS Surpr.
+1427.6%
Revenue
$0.08B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.02
EPS Est.
-$0.10
EPS Surpr.
+120.0%
Revenue
$0.07B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
-$0.09
EPS Est.
-$0.10
EPS Surpr.
+10.0%
Revenue
$0.06B
Q2 FY2025
May 9, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 1 |
| Q4 FY2027 | $0.09 | $0.09 | $0.09 | 1 |
| Q3 FY2027 | $0.09 | $0.09 | $0.09 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +60.8% | $15.86 | $16.40 | +3.40% |
| ▲ Q1 FY2026 | Mar 5, 2026 | +1427.6% | $13.52 | $13.60 | +0.59% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +120.0% | $23.30 | $21.87 | -6.14% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +10.0% | $19.44 | $19.46 | +0.10% |
Q2 FY2026+3.40%
Report Date
May 7, 2026
EPS Beat/Miss
+60.8%
Price Before
$15.86
Price After
$16.40
Q1 FY2026+0.59%
Report Date
Mar 5, 2026
EPS Beat/Miss
+1427.6%
Price Before
$13.52
Price After
$13.60
Q4 FY2025-6.14%
Report Date
Nov 6, 2025
EPS Beat/Miss
+120.0%
Price Before
$23.30
Price After
$21.87
Q3 FY2025+0.10%
Report Date
Aug 7, 2025
EPS Beat/Miss
+10.0%
Price Before
$19.44
Price After
$19.46
Avg Beat Reaction-0.51%
Beat Rate4 / 4 quarters
Largest Move-6.14% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OMDA ends December
Omada Health (OMDA) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.05 — beating the analyst consensus of $-0.13 by +60.8%. OMDA has beaten EPS estimates for 4 consecutive quarters. The next OMDA earnings date is expected around September 1, 2026.
Each quarter, investors track OMDA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OMDA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OMDA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OMDA earnings · 5 questionsOmada Health's next earnings report is expected around September 1, 2026. OMDA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OMDA historically reports after market close (AMC).
OMDA earnings datewhen is OMDA earningsOMDA next earnings datewhen does OMDA report earningsOMDA earnings calendar
▸ Source: FMP · Omada Health SEC filings · US GAAP · Omada Health SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026